title: Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria.
abstract: A single intravenous injection of puromycin aminonucleoside (PAN) results in marked proteinuria and glomerular morphological changes that are similar to minimal change disease in humans. We examined the effect of hydroxyl radical scavengers and an iron chelator on PAN-induced proteinuria. PAN in a dose of 5 mg/100 g body wt significantly increased urinary protein by day 5 (saline: 15 +/- 2, N = 24: PAN: 63 +/- 17, N = 23, P less than 0.001); the proteinuria rapidly increased thereafter, reaching 216 +/- 34, N = 23 by day 7. Concurrent administration of hydroxyl radical scavengers dimethylthiourea, (DMTU 500 mg/kg followed by 125 mg/kg i.p. twice a day) and sodium benzoate (BENZ, 150 mg/kg followed by 125 mg/kg i.p. twice a day) starting the evening before PAN injection markedly reduced proteinuria throughout the course of the study (urinary protein, mg/24 hours on day 7, mean +/- SEM: PAN: 229 +/- 45, N = 15; PAN + DMTU: 30 +/- 5, N = 18; PAN + BENZ: 80 +/- 18, N = 16. Because of the participation of iron in biological systems to generate hydroxyl radical, we also examined the effect of deferoxamine (DFO, 30 mg/day), an iron chelator, on the PAN-induced proteinuria. Concurrent administration of DFO was also protective. In a second series of experiments, DMTU and DFO (administered as described above and then for two additional days after the PAN) provided marked protection even when they were stopped prior to the onset of proteinuria. The protective effects of two hydroxyl radical scavengers and iron chelator implicate an important role for hydroxyl radical in PAN-induced nephrotic syndrome.
authors.affiliation: Department of Medicine, Tulane Medical School, New Orleans, Louisiana.
authors.forename: V
authors.initials: V
authors.lastname: Thakur
authors.forename: P D
authors.initials: PD
authors.lastname: Walker
authors.forename: S V
authors.initials: SV
authors.lastname: Shah
mesh_terms: D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D019817:Benzoic Acid; D003676:Deferoxamine / Q000494:pharmacology; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D006878:Hydroxides; D017665:Hydroxyl Radical; D008297:Male; D011507:Proteinuria / Q000139:chemically induced*; D011691:Puromycin / Q000031:analogs & derivatives*; D011692:Puromycin Aminonucleoside / Q000633:toxicity*; D051381:Rats; D011919:Rats, Inbred Strains; D013890:Thiourea / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D001565:Benzoates; D006878:Hydroxides; D017665:Hydroxyl Radical; D011691:Puromycin; D011692:Puromycin Aminonucleoside; C038983:1,3-dimethylthiourea; D019817:Benzoic Acid; D013890:Thiourea; D003676:Deferoxamine; D004121:Dimethyl Sulfoxide